Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Heng ^a   Ohta, Hidenobu ^a   Tahara, Yu ^b   Nakamura, Sakiko ^c   Taguchi, Kazuaki ^d   Nakagawa, Machiko ^a,e   Oishi, Yoshihisa ^a,f   Goto, Yu Ichi ^f   Wada, Keiji ^g   Kaga, Makiko ^a   Inagaki, Masumi ^a   Otagiri, Masaki ^d   Yokota, Hideo ^c   Shibata, Shigenobu ^b   Sakai, Hiromi ^h   Okamura, Kunihiro ^h   Yaegashi, Nobuo ^h  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c Japan   (Japan)

^d SOJO UNIVERSITY   (Japan)

^e ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^f NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^g NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; ENDOGLIN; ENG PROTEIN, RAT; FLT1 PROTEIN, RAT; N(G) NITROARGININE METHYL ESTER; NANOMATERIAL; SIGNAL PEPTIDE; VASCULOTROPIN RECEPTOR 1;

ANIMAL; BLOOD; BLOOD PRESSURE; BRAIN; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEVELOPMENT; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; METABOLISM; PATHOLOGY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RAT; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; BLOOD SUBSTITUTES; BRAIN; DISEASE MODELS, ANIMAL; ENDOGLIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUMINESCENT MEASUREMENTS; NANOSTRUCTURES; NG-NITROARGININE METHYL ESTER; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84945208043     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15271     Document Type: Article

References (23)

1. Sibai, B., Dekker, G. and Kupferminc, M. Pre-eclampsia. Lancet 365, 785-799 (2005).
2. Myatt, L. and Webster, R. P. Vascular biology of preeclampsia. J Thromb Haemost 7, 375-384 (2009).
3. Powe, C. E., Levine, R. J. and Karumanchi, S. A. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123, 2856-2869 (2011).
4. Chang, T. M. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 4, 221-235 (2005).
5. Kawaguchi, A. T. et al. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke 38, 1626-1632 (2007).
6. Tsukimori, K. et al. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens 21, 477-481 (2008).
7. Verlohren, S. et al. Uterine vascular function in a transgenic preeclampsia rat model. Hypertension 51, 547-553 (2008).
8. Kaga, M. et al. Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model. Life Sci 91, 420-428 (2012).
9. Hakamata, Y., Murakami, T. and Kobayashi, E. Firefly rats as an organ/cellular source for long-term in vivo bioluminescent imaging. Transplantation 81, 1179-1184 (2006).
10. Deguchi, K., Oguchi, K. and Takashima, S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol 16, 296-300 (1997).
11. Back, S. A. Recent advances in human perinatal white matter injury. Prog Brain Res 132, 131-147 (2001).
12. Cai, Z., Pang, Y., Lin, S. and Rhodes, P. G. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975, 37-47 (2003).
13. Witlin, A. G. et al. Adrenomedullin requires an intact nitric oxide system to function as an endogenous vasodilator in rat gestation. Hypertens Pregnancy 22, 9-24 (2003).
14. Gilbert, J. S. et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension 55, 380-385 (2010).
15. Ramesar, S. V., Mackraj, I., Gathiram, P. and Moodley, J. Sildenafil citrate decreases sFlt-1 and sEng in pregnant L-NAME treated Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 157, 136-140 (2011).
16. Freitas, R. A., Jr. Nanomedicine. Biocompatibility, vol IIA (Landes Bioscience, Georgetown, TX, U.S.A) (2003). Date of access: 19/08/2015 http://www.nanomedicine.com/NMIIA.htm.
17. Renkin, E. M. Circulation, Respiration, Body Fluids, Metabolism and Endocrinology. Textbook of Physiology. A. F. F. Harry & Patton, D. Bertil Hille, Ed. (W. B. Saunders, Philadelphia) pp. 860-878 (1989).
18. Sakai, H. et al. Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279, H908-915 (2000).
19. Sou, K., Naito, Y., Endo, T., Takeoka, S. and Tsuchida, E. Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol Prog 19, 1547-1552 (2003).
20. Sakai, H., Tomiyama, K. I., Sou, K., Takeoka, S. and Tsuchida, E. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug Chem 11, 425-432 (2000).
21. Kubota, Y. et al. Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biol Pharm Bull 29, 1756-1758 (2006).
22. Bahtiyar, M. O. et al. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am J Obstet Gynecol 196, 72.e71-76 (2007).
23. Tahara, Y. et al. In vivo monitoring of peripheral circadian clocks in the mouse. Curr Biol 22, 1029-1034 (2012).